EN
TR
EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL
Abstract
m
We aimed to examine the potential beneficial effects of diosmin administration on cisplatin - induced premature ovarian failure (POF) in a rat model
Material and Methods
Twenty-eight rats were divided into four groups. Group A rats (n:7) were determined as the sham group. The remaining rats received an intraperitoneal injection of 1.5 mg/kg/day cisplatin for 10 days to create a POF model. Then, they were randomly divided into 3 subgroups.
Group B was determined as POF group. Group C rats were given 100mg/kg/day diosmin for 10 days simultaneously while creating POF model. Group D rats were given 100mg/kg/day diosmin for 10 days after POF model was created. Twentieth day blood samples were taken and left ovaries were resected for examination.
Results
CIS-induced rats showed reduced levels of SOD, AMH and E2 compared to sham group rats (p<0.05). SOD, AMH and E2 values were not significantly different (p>0.05) between the sham group, group C and D. No significant (p>0.05) difference in FSH value was observed between group C, D and sham groups.
There was no significant (p>0.05) difference in the number of secondary and antral follicles between group C and D compared to the sham group. Primordial follicle count was significantly higher in group C than group B (p<0.05). Primary and total follicle count in group D was significantly (p<0.05) higher than group B.
Conclusion
Diosmin administration after chemotherapy or in combination with chemotherapy has shown helpful efficacy in maintaining the ovarian reserve and the structure of the follicles.
Keywords
Supporting Institution
Yok
Project Number
Yok
References
- Referans1. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9. Published 2006 Apr 6. doi:10.1186/1750-1172-1-9
- Referans2. Mauri D, Gazouli I, Zarkavelis G, et al. Chemotherapy Associated Ovarian Failure. Front Endocrinol (Lausanne). 2020;11:572388. Published 2020 Dec 8. doi:10.3389/fendo.2020.572388
- Referans3. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf. 2005;28(5):401-416. doi:10.2165/00002018-200528050-00004
- Referans4. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-606.
- Referans5. Blumenfeld Z, Evron A. Endocrine prevention of chemotherapy-induced ovarian failure. Curr Opin Obstet Gynecol. 2016;28(4):223-229. doi:10.1097/GCO.0000000000000278
- Referans6. Woad KJ, Watkins WJ, Prendergast D, Shelling AN. The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol. 2006;46(3):242-244. doi:10.1111/j.1479-828X.2006.00585.x
- Referans7. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718-1729. doi:10.1200/JCO.1996.14.5.1718
- Referans8. Huwait E, Mobashir M. Potential and Therapeutic Roles of Diosmin in Human Diseases. Biomedicines. 2022;10(5):1076. Published 2022 May 6. doi:10.3390/biomedicines10051076
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Clinical Research
Publication Date
November 30, 2022
Submission Date
August 24, 2022
Acceptance Date
September 5, 2022
Published in Issue
Year 2022 Volume: 12 Number: 6
APA
Gürsoy, A., & Sade, A. G. (2022). EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine, 12(6), 912-916. https://doi.org/10.16899/jcm.1166435
AMA
1.Gürsoy A, Sade AG. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. J Contemp Med. 2022;12(6):912-916. doi:10.16899/jcm.1166435
Chicago
Gürsoy, Ali, and Ayşe Gökçen Sade. 2022. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine 12 (6): 912-16. https://doi.org/10.16899/jcm.1166435.
EndNote
Gürsoy A, Sade AG (November 1, 2022) EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine 12 6 912–916.
IEEE
[1]A. Gürsoy and A. G. Sade, “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”, J Contemp Med, vol. 12, no. 6, pp. 912–916, Nov. 2022, doi: 10.16899/jcm.1166435.
ISNAD
Gürsoy, Ali - Sade, Ayşe Gökçen. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine 12/6 (November 1, 2022): 912-916. https://doi.org/10.16899/jcm.1166435.
JAMA
1.Gürsoy A, Sade AG. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. J Contemp Med. 2022;12:912–916.
MLA
Gürsoy, Ali, and Ayşe Gökçen Sade. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine, vol. 12, no. 6, Nov. 2022, pp. 912-6, doi:10.16899/jcm.1166435.
Vancouver
1.Ali Gürsoy, Ayşe Gökçen Sade. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. J Contemp Med. 2022 Nov. 1;12(6):912-6. doi:10.16899/jcm.1166435
Cited By
LCZ696 (sacubitril/valsartan) mitigates cyclophosphamide-induced premature ovarian failure in rats; the role of TLR4/NF-κB/NLRP3/Caspase-1 signaling pathway
Life Sciences
https://doi.org/10.1016/j.lfs.2023.121789An overview of different methods to establish a murine premature ovarian failure model
Animal Models and Experimental Medicine
https://doi.org/10.1002/ame2.12477